Several studies have also indicated that women tend to show a greater burden of AD pathology, particularly of p-Tau [41,42,43,44,45,46], and more rapid cognitive decline than men in the mild cognitive impairment (MCI) stage [53,54,55]. The gene discussed is MAPT; the disease is Cognitive impairment.